<DOC>
	<DOCNO>NCT01405911</DOCNO>
	<brief_summary>This study do evaluate safety , efficacy , dose level sitagliptin ( MK-0431/ONO-5435 ) use daily ( qd ) Japanese subject impair glucose tolerance inadequate glycemic control use diet exercise therapy .</brief_summary>
	<brief_title>Dose Response Finding Study MK-0431/ONO-5435 Japanese Subjects With Impaired Glucose Tolerance ( MK-0431-105 )</brief_title>
	<detailed_description />
	<mesh_term>Glucose Intolerance</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Impaired glucose tolerance On diet/exercise therapy Unlikely conceive Meets follow glycemic parameter : Hemoglobin A1c ( Japan Diabetes Society value ) &lt; 6.1 % , Fasting Plasma Glucose &lt; 126 mg/dL , 2hr plasma glucose level 75g oral glucose tolerance test â‰¥140 mg/dL &lt; 200 mg/dL History diabetes mellitus Disease condition clear likely glucose tolerance disorder Previously treat drug prevent diabetes and/or antihyperglycemic drug</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>